As Drug Shortages Linger, Attention Turns to TPN Crisis

The good news is that the number of new drug shortages went down in 2012; the bad news is that the total number of drugs in active shortages is increasing while growing capacity problems are being reported – and shortages of injectable nutrition drugs are especially acute. An FDA economist proposes that rewarding manufacturers for quality may help to alleviate the shortage crisis.